445680 — Curiox BioSystems Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual cashflow statement for Curiox BioSystems Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-14,525	-11,498	-10,042	-8,089	-27,178
Depreciation
Amortisation
Non-Cash Items	7,904	682	-487	-4,228	16,216
Unusual Items
Other Non-Cash Items
Changes in Working Capital	260	-671	413	500	-2,314
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-5,126	-9,888	-8,164	-9,698	-11,109
Capital Expenditures	-261	-841	-212	-258	-136
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-8,050	5,574	3,110	-4,017	1,056
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-8,311	4,734	2,898	-4,275	920
Financing Cash Flow Items	13,087	—	—	-29.9	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	16,999	-237	17,644	19,861	395
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,960	-5,407	12,312	6,279	-9,402